Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis. - Wikidata - wikimedia - TriplyDB

Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis.

Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q34553646

about

Epigenetic therapy in gastrointestinal cancer: the right combination Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy Different definitions of CpG island methylator phenotype and outcomes of colorectal cancer: a systematic review Molecular phenotypes of colorectal cancer and potential clinical applications Different treatment strategies and molecular features between right-sided and left-sided colon cancers Functional Characterization and Drug Response of Freshly Established Patient-Derived Tumor Models with CpG Island Methylator Phenotype Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system.Extramural vascular invasion and response to neoadjuvant chemoradiotherapy in rectal cancer: Influence of the CpG island methylator phenotype.Serrated adenocarcinoma morphology in colorectal mucinous adenocarcinoma is associated with improved patient survival.Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients.Molecular markers predictive of chemotherapy response in colorectal cancer Review of the development of DNA methylation as a marker of response to neoadjuvant therapy and outcomes in rectal cancer.Annexin A10 expression in colorectal cancers with emphasis on the serrated neoplasia pathway Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review.Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors.Molecular Biomarkers in the Personalized Treatment of Colorectal Cancer.Colorectal cancer carcinogenesis: a review of mechanisms Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer.Methylation of a panel of genes in peripheral blood leukocytes is associated with colorectal cancer.Colorectal Choriocarcinoma in a Patient with Probable Lynch Syndrome.DNA Methylation Status of PAX1 and ZNF582 in Esophageal Squamous Cell Carcinoma Tumors with unmethylated MLH1 and the CpG island methylator phenotype are associated with a poor prognosis in stage II colorectal cancer patients Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities.Microsatellite instability: an update.Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for the Clinical Surgeon.Luminally expressed gastrointestinal biomarkers.Lymphoproliferative disorders in patients with rheumatoid arthritis in the era of widespread use of methotrexate: A review of the literature and current perspective.Clinical and prognosis value of the CIMP status combined with MLH1 or p16 INK4a methylation in colorectal cancer.Genetic and epigenetic markers in colorectal cancer screening: recent advances.The therapeutic potential of targeting the BRAF mutation in patients with colorectal cancer.Current and future biomarkers in the treatment of colorectal cancer.DNA methylation aberrancies as a guide for surveillance and treatment of human cancers.The role of LINE-1 methylation in predicting survival among colorectal cancer patients: a meta-analysis.Epstein-Barr virus infection and gene promoter hypermethylation in rheumatoid arthritis patients with methotrexate-associated B cell lymphoproliferative disorders.No association of CpG island methylator phenotype and colorectal cancer survival: population-based study.CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers.Meta-analysis of SIRT1 expression as a prognostic marker for overall survival in gastrointestinal cancer.Prognostic significance of CpG island methylator phenotype in colorectal cancer.Colorectal cancer: epigenetic alterations and their clinical implications.

P2860

Q26745709-B4B26BEA-2BFE-48CC-8F83-A1B6A9BC0594 Q26751035-433BFDDF-3037-4A0E-894F-F90E6B1C1835 Q26768471-14DC3B1F-2520-4D72-B3E3-F019C90B1C67 Q26785725-755EACE0-E35D-4327-AB46-31561767FE05 Q26865322-A32DAE5A-B707-400F-A75C-3C4041720E33 Q28551197-95D92587-0C62-43B2-A387-00E4A367EE8C Q33577619-81D9E9DE-BA36-4139-9C04-DBF1BB35A3BD Q33696207-EA8525C7-4FBC-45BB-BF69-B8C62F7544CF Q33798773-8ED9FD8D-9FA4-4E56-903D-6B91FD93C73E Q34487177-EF64B74E-7FC6-4719-9805-31836155B799 Q35045711-33DC5B38-D331-44E7-B943-90921A6F0571 Q35761956-4F40D20B-B134-4CBF-AEC0-D73F5590AE09 Q35879988-0130C86E-1C26-47B4-B3B6-34187CA7A6E0 Q36037920-74DDE964-3B5E-4D4D-A9E2-08341CF8A92B Q36277022-1C1E9C75-78DB-46F0-AE72-208B20AB7B45 Q36463826-24C237C0-80DC-4D24-B394-C845FA7FBD68 Q36813582-FC6C9FF1-A3DB-4AC1-AB8E-E1F073A75B1D Q36849645-357CE31A-7484-4002-8346-2428CD13048D Q37100708-47365F67-E716-4600-A8A5-A92D06BDA37F Q37121671-6A0797FF-7B60-4711-9781-FC22318528EF Q37447203-6E3781E8-76E4-41C7-8D32-8A241C653C7C Q37678573-741BF842-3E68-4831-A25F-F5D7A80D1130 Q37699262-9C88C012-B8B0-41E0-8B8D-A782A75F6567 Q37737945-60D55EF9-4E18-4B6C-B621-81A712972022 Q38363519-62338BBB-CE11-4D16-A7D4-6DA517A50E6A Q38555225-DEE3750C-EA0A-4391-A6B3-FE5239CB0D60 Q38636313-BDD4EE1B-9706-4837-9C97-2E5EBB170165 Q38652100-2AC1782D-AD98-45A3-9CA3-CB904EE804D3 Q38668770-1D897A84-4CDE-46D3-A5F6-CD3D488D7785 Q38676702-72158DB3-2F22-4377-AD43-957F33525B47 Q38730744-19435518-E73D-4CAD-9BF3-6C27D3CC717A Q38787244-918F315E-C1A7-4EDA-94AC-1F0E7B6AD341 Q39208639-5F66ECF3-DA8C-4D4C-8996-E2A15035E372 Q40273466-5C30A4A3-1344-42E7-88E2-2AE01359D216 Q40444592-EBFF41A4-E3AE-4376-ADC1-45BDA30F7A21 Q40490322-FF40D8FB-F4F7-4B66-8376-3D812BA4C570 Q41066289-3CC987FD-4144-4192-9426-8518387103A4 Q41834358-305CF23E-FD6C-41D6-A386-832463D4530E Q43177934-E59DCF17-8AAD-46AA-8F81-A8BAFB26FFEB Q46112381-923B8B91-C59D-4C54-B795-016676994C1C

P2860

Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q34553646

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Prognostic value of CpG island ...... atic review and meta-analysis.

@ast

Prognostic value of CpG island ...... atic review and meta-analysis.

@en

Prognostic value of CpG island ...... atic review and meta-analysis.

@nl

type

label

Prognostic value of CpG island ...... atic review and meta-analysis.

@ast

Prognostic value of CpG island ...... atic review and meta-analysis.

@en

Prognostic value of CpG island ...... atic review and meta-analysis.

@nl

prefLabel

Prognostic value of CpG island ...... atic review and meta-analysis.

@ast

Prognostic value of CpG island ...... atic review and meta-analysis.

@en

Prognostic value of CpG island ...... atic review and meta-analysis.

@nl

P1433

Q34553646-21F5A5EC-9DDF-4F3F-8349-C3E468106D00

P1476

Q34553646-06E81B24-7EBB-4920-B228-F4E8C20712D3

P2093

Q34553646-1430F3BA-57A8-4489-955E-EBC72131124F

Q34553646-28F120D3-EC77-451D-B479-C26087DB1A01

Q34553646-77BD1D5E-8A95-4D11-9C81-331147CBE608

Q34553646-7E5AFACD-DBCC-4CCA-83EC-CDC6B4F9EA2E

Q34553646-A3B4E236-41D1-4219-B0D1-DFD32E2B8578

Q34553646-A99CA5DC-90BB-4316-9C6F-E1E051953A98

Q34553646-D3A8F5CC-4167-4A84-B0B2-241A08299C67

Q34553646-E743CF16-0FCD-4F98-B8CD-77EB128E86F2

Q34553646-F7714E25-79EC-4796-845A-D76A06B133FE

P2860

Q34553646-0E63562A-F3D9-4946-AE0C-8C81DCEEB4EB

Q34553646-11DCEA1D-3C9B-43BE-A4C7-FB81B29B6512

Q34553646-1D07C896-6967-4F71-A62E-904FF5800176

Q34553646-312900CE-4161-420F-97A7-42746F0ECD48

Q34553646-347E0738-1E00-4B83-9179-2C3BBC1603E8

Q34553646-3954FE3E-9010-411B-9F6E-DA652E7F5414

Q34553646-548AE71E-4C1E-4D2D-AAF7-DF6036399BAF

Q34553646-588CA335-E224-4FF6-A07E-70A2D984D25B

Q34553646-6EE8B31F-3BED-42C1-A199-E2A635B8AD10

Q34553646-7279A2E7-7004-4D2A-BAA5-E96C5B3DC64C

P304

Q34553646-B406D47D-EE02-415F-AFCE-FCEE63AAC526

P31

Q34553646-26A5B474-9E0B-44A0-B7ED-751C375BCB24

Q34553646-d485e7a4-4440-4fb6-81ba-565fc0f1f68e

P356

Q34553646-9AAC85FA-4BF1-4E6E-99A6-3696E26EFB4A

P433

Q34553646-DCF457DB-BAAE-45DC-80D9-5FE65144007C

P478

Q34553646-7ED1CDA7-C3F3-405E-88A6-A0F47F595D2E

P50

Q34553646-0C31D380-29A2-402D-A276-5DA388839D65

Q34553646-8B8CFD32-38C8-4761-A003-AF4D5302EE83

P577

Q34553646-CA656948-9A60-4A67-BC61-E3A44CFABC9A

P5875

Q34553646-F5734E5E-6C9B-4205-9450-89C186E95B64

P698

Q34553646-79265BE1-C82C-4F11-9ECE-AE6F582CAFCC

P921

Q34553646-7CECC8D3-E998-47AC-883F-9B5D2A5A2DBA

Q34553646-B309AA05-FCAD-4E93-BEDF-55CEEDF75743

Q34553646-DD93E121-9D2F-4B07-8500-544946237C8D

P932

Q34553646-EEA2DCBF-1978-44DB-B486-5A79D7010494

P356

P1433

Annals of Oncology

P1476

Prognostic value of CpG island ...... matic review and meta-analysis

@en

P2093

D Y Zhang

http://www.w3.org/2001/XMLSchema#string

E P Pappou

http://www.w3.org/2001/XMLSchema#string

H H Juo

http://www.w3.org/2001/XMLSchema#string

H Wang

http://www.w3.org/2001/XMLSchema#string

M van Engeland

http://www.w3.org/2001/XMLSchema#string

N Ahuja

http://www.w3.org/2001/XMLSchema#string

S Baylin

http://www.w3.org/2001/XMLSchema#string

T Yu

http://www.w3.org/2001/XMLSchema#string

Y Y Juo

http://www.w3.org/2001/XMLSchema#string

P2860

The fundamental role of epigenetic events in cancer

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Quantifying heterogeneity in a meta-analysis

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

Modulation of fluorouracil antitumor activity by folic acid in a murine model system

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma

Gene silencing in cancer in association with promoter hypermethylation

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

P304

2314-2327

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDU149

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Fabian M. Johnston

Hariharan Easwaran

P577

2014-04-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261520711

http://www.w3.org/2001/XMLSchema#string

P698

24718889

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

4239805

http://www.w3.org/2001/XMLSchema#string